K250309

Substantially Equivalent

BTL-199

Applicant: BTL Industries, Inc.
Product code: QPL
Advisory panel: Neurology
Date received: 2025-02-03
Decision date: 2025-08-07
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Marlborough, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.